(Q41123582)

English

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 30 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial (English)

1 reference

Europe PubMed Central

27 September 2017

phase III clinical trial

0 references

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Ming Zeng

1

1 reference

Europe PubMed Central

27 September 2017

Xu-Hu Mao

2

1 reference

Europe PubMed Central

27 September 2017

Jing-Xin Li

3

1 reference

Europe PubMed Central

27 September 2017

Wen-De Tong

4

1 reference

Europe PubMed Central

27 September 2017

Bin Wang

5

1 reference

Europe PubMed Central

27 September 2017

Yi-Ju Zhang

6

1 reference

Europe PubMed Central

27 September 2017

Gang Guo

7

1 reference

Europe PubMed Central

27 September 2017

Zhi-Jing Zhao

8

1 reference

Europe PubMed Central

27 September 2017

Liang Li

9

1 reference

Europe PubMed Central

27 September 2017

De-Lin Wu

10

1 reference

Europe PubMed Central

27 September 2017

Dong-Shui Lu

11

1 reference

Europe PubMed Central

27 September 2017

Zhong-Ming Tan

12

1 reference

Europe PubMed Central

27 September 2017

Hao-Yu Liang

13

1 reference

Europe PubMed Central

27 September 2017

Chao Wu

14

1 reference

Europe PubMed Central

27 September 2017

Da-Han Li

15

1 reference

Europe PubMed Central

27 September 2017

Ping Luo

16

1 reference

Europe PubMed Central

27 September 2017

Hao Zeng

17

1 reference

Europe PubMed Central

27 September 2017

Wei-Jun Zhang

18

1 reference

Europe PubMed Central

27 September 2017

Jin-Yu Zhang

19

1 reference

Europe PubMed Central

27 September 2017

Bo-Tao Guo

20

1 reference

Europe PubMed Central

27 September 2017

Feng-Cai Zhu

21

1 reference

Europe PubMed Central

27 September 2017

Quan-Ming Zou

22

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

30 June 2015

1 reference

Europe PubMed Central

27 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

27 September 2017

386

1 reference

Europe PubMed Central

27 September 2017

10002

1 reference

Europe PubMed Central

27 September 2017

1457-1464

1 reference

Europe PubMed Central

27 September 2017

Helicobacter pylori: epidemiology and routes of transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Helicobacter pylori infection and the risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A humble bacterium sweeps this year's Nobel Prize

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinician-discoverers--Marshall, Warren, and H. pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of vaccines against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-toxic derivatives of LT as potent adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic correlates of protection induced by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960310-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(15)60310-5

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41123582&oldid=2094093515"